SCHEDULE 13G/A: Joseph C. Sardano Discloses 7.1% Beneficial Ownership in Sensus Healthcare, Inc.
Beneficial Ownership Disclosure
Joseph C. Sardano has filed an amended Schedule 13G, revealing a 7.1% beneficial ownership stake in Sensus Healthcare, Inc., comprising 1,175,293 shares of common stock.
Summary
- Joseph C. Sardano beneficially owns 1,175,293 shares of Sensus Healthcare, Inc. common stock.
- This ownership represents 7.1% of the total outstanding common stock of Sensus Healthcare, Inc.
- Mr. Sardano holds sole voting power and sole dispositive power over all 1,175,293 shares.
- This filing is an Amendment No. 2 to Schedule 13G, triggered by an event on September 14, 2023.
- The filing was signed by Joseph C. Sardano on May 21, 2025.
Sentiment
Score: 6
Explanation: The filing indicates a significant beneficial ownership stake by an individual, Joseph C. Sardano, which can be viewed as a positive sign of insider confidence and alignment with shareholder interests, though it is a routine disclosure.
Positives
- A significant beneficial ownership stake (7.1%) by an individual, Joseph C. Sardano, indicates strong alignment with shareholder interests.
- Mr. Sardano retains sole voting and dispositive power over his shares, suggesting direct control over his investment.
Negatives
- None directly stated in the filing.
Risks
- No specific risks are detailed in this Schedule 13G filing, as it is primarily a disclosure of beneficial ownership.
Future Outlook
This Schedule 13G filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding the company's future outlook.
Management Comments
- This filing is a disclosure of beneficial ownership and does not include direct management comments or quotes.
Industry Context
This filing is a disclosure of individual beneficial ownership in Sensus Healthcare, Inc., a company operating in the healthcare sector, and does not provide specific industry context or trends.
Comparison to Industry Standards
- This filing is a disclosure of individual beneficial ownership and does not contain information for comparison to industry standards or specific comparable companies/projects.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
Legal Proceedings
- This filing does not mention any legal or regulatory proceedings.
Related Party Transactions
- This filing does not disclose any related party dealings.
Stakeholder Impact
- Shareholders may view the significant insider ownership as a positive indicator of management's vested interest in the company's performance.
Next Steps
- The document does not outline specific future actions, events, or milestones for the company or the reporting person beyond the filing itself.
Key Dates
| Date | Description |
|---|---|
| 09/14/2023 | Date of event which required the filing of this statement. |
| 05/21/2025 | Signature date of the Schedule 13G Amendment No. 2 filing by Joseph C. Sardano. |
Recommendation
holdKeywords
Sensus Healthcare, Joseph C. Sardano, Schedule 13G, beneficial ownership, common stock, SEC filing, healthcare, medical devices
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.